
|Articles|September 28, 2012
How to Reach First-in-Man Studies Successfully
Author(s)Angie Drakulich
What’s the best way to reach first-in-man studies when you have little to no information? Bioavailability issues, financial constraints.
Advertisement
What’s the best way to reach first-in-man studies when you have little to no information? Bioavailability issues, financial constraints, and pressure to meet accelerated deadlines can affect development, so having a firm plan in place is key. PharmTech is hosting a free educational
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Brent Wilhelm on Cold Chain Pharmaceuticals Reshaping Shipping Needs
2
Everything to Know about BMS & NVidia’s AI Supercomputer
3
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
4
Ask the Expert: Drug Approval Submissions
5

